OBJECTIVES: It has been well recognized that health-care cost is strongly dependent on age. The study aims at estimating the magnitude and distribution of lifetime medical costs. METHODS: We employ a period life table model using single year's medical expenditures from Korea National Health Insurance Corporation, population data and life table from Korean Statistical Agency. To estimate lifetime medical costs for male and female, 100,000 hypothetical cohorts for each sex whose mortality rate coming from life table is constructed and assigned to medical costs at each age and sex. This procedure permits us to estimate lifetime medical costs at each age and for each sex. The method used here is to conceptually convert cross-sectional costs data into a longitudinal pattern of costs, which generates profi les of medical cost from birth to death. RESULTS: The average member of the birth cohort will spend 74,150 thousands Won (98,883 PPP US$) for man and 87,868 thousands Won (117,177 PPP US$) for woman in 2007 over the course of his or her life. Total lifetime medical cost is 19 percent higher for females than males due to mainly life expectancy difference. For the average life table member, half of all lifetime cost occurs after about age 65. We also estimate the distribution of lifetime medical cost by phases of life course. For a male (female), 12.7 (9.2) percent of a cohort's expenditures occurs from birth to age 19; 8.4 (10.0) percent accrues during ages 20~39; 30.2 (28.4) percent is expended during ages 40~64; 42.7 (44.0%) percent is realized during ages 65~84; 5.9(8.4) percent accrues over age 85. CONCLUSIONS: The fi ndings of this study are similar to the patterns of medical costs of other countries' experiences provided by other literatures-high during infancy, low during childhood and young adulthood, then rising during middle-age and rapidly growing during the senior years.
PHP19 THE COST OF ILLNESS IN KOREA (2007)
Jung YH Korea Institute for Health and Social Affairs, Seoul, South Korea OBJECTIVES: Illness is associated with signifi cant economic burden on both individual and society. This study aims at measuring the cost of illness in Korea in 2007. METHODS: We estimate both direct and indirect costs of illness using a prevalencebased approach. Direct cost includes medical expenditures (inpatient, outpatient), caregiver's cost and traffi c costs. As indirect costs, productivity loss representing lost workdays due to illness and lost earnings due to premature death is estimated based on human capital theory. The results are reported according to age, sex, diseases and each cost items in USA Purchasing Power Parity (PPP) Dollars at 3% discount rate. The major data sources are National Health Insurance Statistical Yearbook, Annual Report on the Cause of Death Statistics, and Survey Report on Wage Structure. We also use other information such as the Korean Statistical Information System. We provide the results according to age, sex, and diseases at each cost items.
RESULTS:
The cost of illness of Korea in 2007 is 56,633,552 million Won (75,523 million PPP US$) based on 3% discount rate, which represents approximately 6.28% of GDP. Of this total, 47.8% (36,065 million PPP US$) is devoted to medical costs, followed by productivity loss (46.4%; 35,053 million PPP US$), caregiver's costs (3.9%; 2,962 million PPP US$), and transportation cost (1.9%; 1,444 million PPP US$). The cost of illness is higher for males (45,912 million PPP US$) than females (29,611 million PPP US$), which results from the difference of productivity loss cost. However, direct cost of females is higher than that of males. We fi nd that the cost of aged 40~49 accounts for the highest proportion (23.5%) followed by aged 50~59 (22.5%). The four major diseases incurring highest costs are as follows; neoplasms (18.76%), circulatory system (13.92%), digestive system (13.55%), and respiratory system (10.53%). CONCLUSIONS: This study could provide basic information for establishing prioritizations of health policies to reduce economic burden of illness and enhance quality of life. 
PHP20 TRENDS IN DRUG EXPENDITURES IN SONGKHLA HOSPITAL

PHP21 WHAT ARE THE TOP MOST COSTLY DISEASES FOR USA? THE ALIGNMENT OF BURDEN OF ILLNESS WITH PREVENTION AND SCREENING EXPENDITURES
Kockaya G 1 , Wertheimer A 2 1 Istanbul University Istanbul Medical Faculty, Istanbul, Turkey; 2 Temple University School of Pharmacy, Philadelphia, PA, USA OBJECTIVES: It was the intention of the authors to generate a list of the top diseases responsible for the greatest fi nancial expense in the United States. This listing would then inform policymakers as to the highest priority target conditions. With such information available, funding for the NIH could be accomplished based upon factual criteria rather than political clout or uninformed consensus. METHODS: The fi rst step was a literature review to explore articles and reports which were published about the cost of illness (COI) up to December 2009. Therefore the source of the data used in this investigation was obtained from this retrospective search approach. RESULTS: With reference to total cost for disease, fi rst was HCVD with US$475.3 billion, followed by alcohol abuse and substance at US$300.6 billion, digestive diseases at US$259.6 billion, cancer at US$239.5 billion and mental disease at US$216.6 billion. CONCLUSIONS: As has been seen, the total societal costs of the diseases do not synch with the degree of attention paid to these various disease states. Several of the diseases have very powerful and vocal support organizations that encourage attention and clinical research support. On the other hand we hear very little about efforts against allergic rhinitis or infectious and parasitic diseases. 
PHP22 UNIT COST OF BURMESE TRANSLATOR ACTIVITIES IN PHARMACY DEPARTMENT, SAMUTSAKHON HOSPITAL
RESULTS:
The results of this study found that labor cost of Burmese translator is 0.98 bath/min, and unit cost of each activity included translating drug information for general patients costs 2.45 bath/case,while, dispensing vitamins for Burmese pregnancies which costs about 0.98 bath/case. Although giving drug information for TB and AIDs patients is 4.9 bath/case or translating the evaluating adverse drug reaction is 9.8 bath/case. The most expensive cost is teaching to use special device for asthmatic patients about 14.7 bath/case. There are other assignments, for example, preparing Burmese drug leafl ets or prepack medicines. Every activities are under responsibed by Thai pharmacists. CONCLUSIONS: From this study is quite similar to labor cost of Nurse assistants at Ledsin Hospital, Bangkok in 2005 (0.81 bath/min). Also, this information can be applied for other hospitals that in the similar situation. This study can help decision-maker to spend more budget to improve quality of pharmaceutical care with humanity.
PHP23 HEALTH DECENTRALIZATION, GOVERNMENT HEALTH EXPENDITURE AND HEALTH OUTCOME IN CHINA
Chen Q, Li L Peking University, Beijing, China OBJECTIVES: Since the early 1980s, decentralization has reemerged as a valued political and economic goal in most developing countries. China's health-care system is also in the process of decentralization, local governments take more responsibilities of health sector, accompanied by the diminution of public role in health fi nancing especially after the fi scal reform in 1994. This research looks at the health outcome (both the level and gradient) during the period 1991-2007 to identify the effects of these policy changes on health outcomes in China. METHODS: we borrow the micro Grossman health production model using province-level pooled cross-section and time-series data during the period 1991-2007. We fi rst investigates the "overall" and "partial" effect of income on health, and then focus on the policy effects. Life expectancy, infant mortality, mortality, and maternal mortality are examined as health variables (level, gradient, and convergence). Medical care, public health, socioeconomic, environmental factors as well as institutional variables are considered in the production function. RESULTS: The results are coincident with theoretical expectation i.e., economic growth alone does not promote health in typical developing countries, but some channels like its impact on public health do, and also the system does matter. The decentralization of government responsibilities and reduction of public role are signifi cant for the fall of mortality and infant mortality and both signifi cantly affect the sigma and beta convergence of health
